Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Stage 3 lower case b

Known as: stage 3b, stage iiib 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Five-year survival rates for non–small cell lung cancer (NSCLC) range from 14% to 49% for stage I to stage IIIA disease, and are… Expand
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2011
Highly Cited
2011
BACKGROUND NF-E2-related factor 2 (Nrf2) plays an important role in platinum chemoresistance by activating transcription of… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2009
Highly Cited
2009
BACKGROUND Vascularized iliac bone-grafting has been reported to be successful for patients with osteonecrosis of the femoral… Expand
  • figure 1
  • figure 2
  • figure 3
2007
2007
BackgroundThe aim of the present study was to identify the clinicopathological factors affecting locoregional recurrence (LRR) in… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2004
Highly Cited
2004
PURPOSE To improve treatment outcome for patients presenting with inflammatory breast cancer (IBC), we have sequentially… Expand
Highly Cited
2004
Highly Cited
2004
PURPOSE AND METHODS Docetaxel second-line chemotherapy for non-small-cell lung cancer (NSCLC) has previously been shown to… Expand
Highly Cited
2002
Highly Cited
2002
PURPOSE To define clinical and pathologic predictors of local-regional recurrence (LRR) for patients treated with neoadjuvant… Expand
Highly Cited
1999
Highly Cited
1999
PURPOSE In a previous phase I study cisplatin (CDDP), gemcitabine (GEM), and vinorelbine (VNR) combination therapy was safe and… Expand
1998
1998
PURPOSE To see if changes in tumor/blood glutathione (GSH) levels after one fraction of radiotherapy can be correlated with the… Expand
Highly Cited
1997
Highly Cited
1997
This study was performed to determine whether pleural effusion in patients with advanced non-small cell lung cancer (NSCLC) has a… Expand
  • table 1
  • table 2
  • figure 2